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Objective: To histologically and radiographically evaluate soft (primary outcome) and hard 
tissue integration of two-piece titanium and zirconia dental implants with/without buccal 
dehiscence defects.  
Materials & Methods: In 6 dogs, five implants were randomly placed on both sides of the 
mandible: i) Z1: a zirconia implant (modified surface) within the bony housing, ii) Z2: a 
zirconia implant (standard surface) within the bony housing, iii) T: a titanium implant within 
the bony housing, iv) Z1_D: a Z1 implant placed with a buccal bone dehiscence (3mm in height, 
identical width to implant body), and v) T_D: a titanium implant placed with a buccal bone 
dehiscence. Two weeks of healing and 6 months of loading were applied on each hemi-
mandible, respectively. 
Results: The median level of the margo mucosae shifted more apically over time in all groups 
(borderline statistical significance in groups Z1_D: -0.52 mm and T_D: -1.26 mm). The median 
height of the peri-implant mucosa in groups Z1_D and T_D was greatest at 2 weeks and 6 
months, but the linear change in the peri-implant mucosa was significant only for group T_D 
over time (-1.45 mm). Z1 demonstrated a higher bone-to-implant contact compared to Z2 and 
T. Minimal change of radiographic marginal bone levels in all groups were observed (less than 
1 mm).  
Conclusion: When buccal dehiscence was presented, titanium implants presented significant 
loss of peri-implant mucosal height compared to zirconia implants with a modified surface, 
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Introduction 
Titanium and titanium-based alloys are considered as the gold standard materials for dental 
implants (Hisbergues, Vendeville, Vendeville, 2009), due to excellent tissue response and 
mechanical properties (Steflik, Corpe, Young, Buttle, 1998). A large number of clinical studies 
demonstrated high implant survival rates for various clinical indications in partially edentulous 
patients (Jung, Zembic, Pjetursson, Zwahlen, Thoma, 2012; Pjetursson, Thoma, Jung, Zwahlen, 
Zembic, 2012; Roccuzzo, Bonino, Gaudioso, Zwahlen, Meijer, 2012). Reported disadvantages 
and limitations for titanium implants, however, included hypersensitivity, corrosion, esthetic 
problems and susceptibility to bacterial peri-implant adhesion (Cionca, Hashim, Mombelli, 
2017).  
Zirconia was introduced as an alternative material to compensate for some of these limitations 
and to meet patient demands for metal-free reconstructions. Biological properties of zirconia 
implants were thoroughly investigated on both the hard and soft tissue levels, and also in 
comparison to titanium implants. Scientific evidence demonstrated no significant differences 
in the degree of osseointegration with or without bone augmentation procedures between 
zirconia and titanium implants (Benic, et al., 2017; Hafezeqoran, Koodaryan, 2017), thereby 
indicating the suitability of zirconia implants for clinical use. Moreover, even though limited, 
experimental data demonstrated dimensional and morphologic similarities in the peri-implant 
mucosa between zirconia and titanium implants (Tete, Mastrangelo, Bianchi, Zizzari, Scarano, 
2009; Thoma, et al., 2015; Welander, Abrahamsson, Berglundh, 2008). 
Observational studies indicated that dental implants may not always be completely embedded 
by bone even though demonstrating clinically successful tissue integration at 7 and 10 years 
respectively (Benic, et al., 2012; Kuchler, Chappuis, Gruber, Lang, Salvi, 2016). This 
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observation may be due to continuous remodeling processes of the alveolar ridge or failing 
GBR procedures, but also suggests that the peri-implant soft tissues can compensate for 
missing hard tissue. In a recent clinical trial, buccal bony dehiscence defects around titanium 
implants were intentionally left without guided bone regeneration, thereby exposing the rough 
titanium surface to the peri-implant soft tissues (Jung, et al., 2017). Healthy and stable soft 
tissues, but more marginal bone loss at sites with bony dehiscence compared to augmented 
sites were reported at 18 months of follow-up. Due to an excellent biocompatibility, favorable 
soft tissue integration and a minimized plaque accumulation (Tete, et al., 2009; Welander, et 
al., 2008), speculation has been raised that zirconia implants might be more favorable than 
titanium implants in case of (un)intentionally exposed implant threads. 
The aims of the present study were, therefore, to histologically and radiographically evaluate 
soft and hard tissue integration of two-piece titanium and zirconia dental implants with and 
without buccal dehiscence defects.  
  
 7 
Materials and methods 
The present study was designed following the ARRIVE guidelines for preclinical research 
(Kilkenny, et al., 2010). A total of six mongrel dogs (> 2 years old) weighing a maximum of 
30 kg were selected. All surgeries were carried out at Yonsei Medical Research Center, Seoul, 
South Korea. The experimental protocol was approved by the Institutional Animal Care and 
Use Committee (Approval no. 2017-0333). All dogs were housed at a room temperature of 15–
20°C and a humidity of >30% and provided individual access to water ad libitum and a soft 
diet throughout the entire study period. All animals were checked medically and dentally 2 
weeks before the initiation of the first surgery. Supragingival calculus removal and plaque 
control were carried out prior to the surgical phase. Throughout the experimental period, a soft 
diet was provided. 
Surgical procedures 
A detailed schedule of the interventions is presented in Figure 1. 
On the day of the surgery, the general health of all animals was checked and documented. All 
surgical procedures were performed under general anesthesia. General anesthesia was induced 
by an intravenous injection of atropine (0.04 mg/kg; Kwangmyung Pharmaceutical, Seoul, 
Korea) and an intramuscular injection of a combination of xylazine (Rompun, Bayer Korea, 
Seoul, Korea) and ketamine (Ketara, Yuhan Corporation, Seoul, Korea), then followed by an 
inhalation anesthesia (Gerolan, Choongwae Pharmaceutical, Seoul, Korea). The postsurgical 
management included daily irrigation with 0.2% chlorhexidine solution (Hexamedin, Bukwang 
Pharmaceutical, Seoul, Korea), and an intramuscular injection of antibiotics (20 mg/kg; 
cefazolin sodium, Yuhan, Seoul, South Korea) and analgesic (Meloxicam, Boehringer 
Ingelheim, Bogota D.C., Colombia).  
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The surgical protocol and the validity of the present model were previously described (Lim, et 
al., 2018).  
Tooth extraction and creation of chronic defects 
All mandibular premolars (P1, P2, P3 and P4) and the first molar (M1) on both sides of the 
mandible were extracted. For that purpose, a full thickness flap was elevated, and teeth 
separated to prevent fractures. Following extraction, a one-wall defect was prepared by 
removing the buccal bone plate in the surgical sites randomized to undergo implant placement 
with dehiscence defects. In all other sites, the extraction sockets were left intact. Primary 
wound closure was then obtained. 
Implant placement  
Implant placement was performed in a staged manner on the left and right sides of the mandible 
to allow for two healing time-points (6 months and 2 weeks, respectively). On one side of the 
mandible in each dog, a mid-crestal incision made from the canine to the second molar, and 
mucoperiosteal flaps reflected. Five osteotomies were prepared, and dental implants placed 
according to the manufacturer's recommendation, thereby allocating 5 experimental groups 
bilaterally in each dog (n=6 for each healing time-point) and based on a computer-generated 
randomization list: (Fig. 2a): 
(i) Z1: zirconia implant (AXIS HEXALOBE™ with a modified surface, Ø4.0 x 8 mm; 
AXIS Biodental, Les Bois, Switzerland) placed within the bony housing, 
(ii) Z2: zirconia implant (AXIS HEXALOBE™, Ø4.0 x 8 mm; AXIS Biodental) placed 
within the bony housing, 
(iii) T: titanium implant (CAMLOG® SCREW-LINE promote® plus, Ø3.8 x 9 mm, Camlog 
Biotechnologies, Basel, Switzerland) placed within the bony housing, 
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(iv) Z1_D: Z1 implant placed with buccal bone dehiscence, 
(v) T_D: Titanium implant placed with buccal bone dehiscence. 
Z2 surface is a moderately rough surface with Ra ≈ 1.6 µm, achieved by a ceramic injection 
molding process. Z1 surface is a modified surface from Z2 surface using a hydroxyapatite (HA) 
coating with biomimetic dimensions. 
At least 2 mm of buccal bone was present after implant placement in groups Z1, Z2, and T. In 
groups Z1_D and T_D, the height of buccal bone dehiscence was 3 mm and the width was 
identical to the implant body.  
For zirconia implants, the final position of the implant shoulder was 0.7 mm above the bone 
crest. For titanium implants, the border between the rough and smooth surface was located at 
the level of the alveolar crest (implant shoulder was located 0.4 mm above the bone crest). 
Healing abutments were then positioned for transmucosal healing and flaps adapted. 
Crown insertion 
After a healing period of 8 weeks following implant placement (Fig. 2b), prefabricated 
CAD/CAM crowns were inserted on all implants on one side of the mandible (Fig. 2c). In order 
to fabricate the crowns, one zirconia and one titanium implant were inserted in a plaster model. 
Then, a PEKK (poly ether ketone ketone) and a hybrid abutment (titanium basis) were 
connected to the zirconia and the titanium implants. These situations were scanned using an 
intraoral (3Shape, Copenhagen, Denmark). The scanned images were transferred to a 
CAD/CAM system (3Shape dental designer, 3Shape) in order to produce crowns with a screw 
access hole. The crowns were cemented to the abutments extra-orally, and any cement remnant 
completely removed. The crown-abutment was connected to the implant using a screw. 
Implant placement on opposite side of the mandible 
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Thirty weeks after implant placement on one side of the mandible and 2 weeks prior to sacrifice 
(38 weeks after tooth extraction), dental implants were placed according to the above-
mentioned protocol and left for transmucosal healing on the other side of the mandible. Thereby, 
a healing period of 2 weeks was established. No crowns were inserted on these implants. 
Sacrifice 
After 2 weeks following the second implant surgery, the dogs were sacrificed with an 
intravenous overdose of sodium pentobarbital, resulting in 6 months of loading on one side of 
the mandible and 2 weeks of healing after implant placement on the other side of the mandible. 
Implants and surrounding tissues were macroscopically inspected, and tissue sections 
containing the implants resected (Fig. 2d). 
Histological preparation  
The harvested tissue sections were immersed in 10% neutral-buffered formalin for 10 days. 
Then, the specimens were trimmed, dehydrated in ethanol and embedded in methyl 
methacrylate. A central bucco-oral section for each implant site was prepared at 40-50 µm 
thickness using a microcutting and grinding technique adapted by Donath and Breuner (Donath, 
Breuner, 1982). Thereafter, the sections were stained with van Gieson. 
Intraoral radiographs 
Intraoral x-rays were taken using a standardized parallel technique at implant placement, at 




The images from the histological slides were observed using a light microscope (Leica 
DM6000 B; Leica Mikrosysteme, Wetzlar, Germany) equipped with a digital camera (Leica 
DFC 450; Leica Mikrosysteme), and each image was then digitally scanned for image analysis. 
The acquired images were processed (Photoshop CS6, Adobe, California, USA) and analyzed 
(Leica Application Suite Ver. 4.3, Leica Mikrosysteme). 
Peri-implant soft tissue dimensions and bone-to-implant contact 
The following landmarks were identified (Thoma, et al., 2015): (i) the margo mucosa, MM; (ii) 
the implant shoulder, IS; (iii) the apical extension of the junctional epithelium, aJE; (iv) the 
first bone-to-implant contact, fBIC; and (v) the bone crest, BC. Using these landmarks, the 
following linear parameters were measured: (i) the level of the margo mucosa relative to the 
implant shoulder, MM-IS; (ii) the length of the junctional epithelium, MM-aJE; (iii) the length 
of peri-implant mucosa, MM-fBIC; (iv) the distance between IS and fBIC, subtracted by 
0.7mm (zirconia implant) or 0.4mm (titanium implant), due to the two different insertion 
protocols and height of the implant collars, IS-fBIC_c; and (v) the distance between the bone 
crest and the fBIC, BC-fBIC (Fig. 3a).  
A region of interest (ROI) was defined with a length of 4mm on the buccal and lingual side of 
each implant. Then, the mean bone-to-implant contact (BIC, %) was calculated on the buccal 
and lingual side and then averaged (Fig. 3b).  
Radiographic analysis 
All digital x-ray images were transferred into a software program (Photoshop CS6, Adobe, 
California, USA), and the first bone-to-implant contact (fBIC) was measured on the mesial and 
distal surfaces using the known pitch distance between the implant threads. Marginal bone level 





The statistical analyses were performed with the software SAS 9.4 (SAS Cary N.C. USA) 
The metric variables with mean, standard deviations, median and quartiles were described. 
Since several treatments and measurements are clustered within the same dog, mixed linear 
models were applied for the analyses of the fixed effects as time and treatment, including their 
interaction. However, this interaction was not significant, also possibly due to the small sample 
size. Hence, only the time or the treatment effect was investigated for the corresponding 
subgroups of data. 
Pairwise comparisons in case of a significant effect are adjusted for the multiple testing by 






All dogs remained healthy during the entire study period and the healing was uneventful in all 
experimental sites. No implants or crowns were lost. 
Histomorphometric analyses 
The data of the linear measurement are presented in Table 1. The data for the percentages of 
the bone-to-implant contact (BIC) are presented in Table 2.  
Representative histologic views at 2 weeks of healing and at 6 months of loading are presented 
in Figure 4. 
Peri-implant soft tissue dimensions 
The median level of the margo mucosae was located coronally relative to the implant shoulder 
(MM-IS) on the buccal side, ranging between 1.63 mm (Q1= 1.57; Q3= 3.09) for group Z1_D 
and 2.64 mm (1.68; 3.47) for group T in the 2-week healing groups, and between 1.23 mm 
(1.01; 1.58) for group Z1_D and 1.63 mm (1.13; 2.11) for group T in the 6-month loading 
groups (intergroup comparisons p>0.05). Over time, the margo mucosae shifted more apically 
in all groups. Median changes ranged between -1.4 mm (-1.86; 0.21) for group T and -0.36 mm 
(-0.59; -0.17) for group Z1. Intragroup changes for groups without dehiscence defects were not 
statistically significant (p>0.05). The changes in groups Z1_D [median= -0.52 mm, (Q1= -0.65; 
Q3= -0.32)] and T_D [-1.26 mm, (-1.47; -0.5)], however, demonstrated a borderline statistical 
significance (p=0.063 for both groups). The group effect for the change of the level of MM 
was not statistically significant (p>0.05). 
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The median height of the peri-implant mucosa (MM-fBIC) in groups Z1_D [5.14 mm, (4.55; 
5.23)] and T_D [5.43 mm, (5.19, 5.88)] was distinctively greater than in the other groups at 2 
weeks. At 6 months of loading, the values of MM-fBIC were highest in groups Z1_D [4.51 
mm, (4.3; 4.6)], followed by T_D [3.95 mm, (3.24; 4.31)], Z2, Z1 and T. Group Z1_D 
demonstrated statistically significantly differences compared to groups Z1, T and T_D 
(p<0.05). The change of MM-fBIC between 2 weeks and 6 months was statistically significant 
in group T_D [-1.45 mm, (-2.42; -1.06)] only. There was a statistically significant intergroup 
difference for the change of MM-fBIC between groups T_D and Z1 [0.58 mm, (0.19; 0.96), 
p=0.006] and between groups T_D and Z2 [0.42 mm, (-0.34; 1.13), p=0.009 (not-adjusted)].  
The median length of the junctional epithelium (MM-aJE) was shorter for zirconia implants 
without dehiscence defect (0.88 and 0.62 mm for groups Z1 and Z2, respectively) than for all 
other groups at 2 weeks. At 6 months of loading, the median MM-aJE in groups Z1 (2.45 mm) 
and T (2.02 mm) were higher than in groups Z1_D (1.0 mm) and T_D (1.27 mm). Intergroup 
differences at 2 weeks and 6 months as well as changes between 2 weeks and 6 months were 
not statistically significant (p>0.05).  
The corrected distances between IS and fBIC (IS-fBIC_c) in groups Z1_D (median= 2.81 mm, 
at 2-week healing, 2.65 mm at 6-month loading) and T_D (2.91 mm at 2-week healing, 2.01 
mm at 6-month loading) were greater than in the other groups at both time points. The changes 
of IS-fBIC_c in all groups was not statistically significant over time (p>0.05), but there was a 
statistically significant intergroup difference between groups Z1 [1.04 mm, (0.84; 1.51)] and 
T_D [-0.71 mm, (-1.77;  0.68)] (p=0.018, not-adjusted). 
Bone-to-implant contact 
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At 2 weeks of healing, the median percentage of the bone-to-implant contact (BIC) was highest 
in group Z1 [46.49, (37.15; 53.10)], followed by T_D, T, Z1_D and Z2, and there was 
statistically significant difference between groups Z1 and Z2 (p=0.0296, not-adjusted). At 6 
months of loading, the median percentages of BIC in groups Z1 [83.53, (80.24; 88.38)] and 
Z1_D [85.39, (82.31; 90.08)] were higher than other groups (borderline p value=0.058). 
Radiographic analysis 
In the 2-week healing groups, the median value of the change of the marginal bone level 
(MBchange) was minimal. In the 6-month loading groups, MBchanges between implant 
placement and crown insertion were statistically significant in groups Z1 [-0.8 mm, (-0.99; -
0.62)] and T [-0.52 mm, (-0.82; -0.02)] (p=0.031 for both groups). However, MBchanges 
between crown insertion and sacrifice and between implant placement and sacrifice were not 
statistically significant in all groups (p>0.05). No statistically significant group effect was 




The present study evaluating hard and soft tissue integration of two-piece titanium and zirconia 
dental implants with and without buccal dehiscence defects demonstrated that (i) the level of 
the margo mucosae shifts more apically over time in all group (but to an extent of borderline 
statistical significance in groups with dehiscence defects; Z1_D and T_D), (ii) the height of the 
peri-implant mucosa in groups Z1_D and T_D was greatest both at 2 weeks and 6 months, iii) 
the change in height of the peri-implant mucosa was significant for group T_D and included a 
change in both hard and soft tissues, whereas in group Z1_D no significant changes were 
observed, (iv) Z1 implants enhanced osseointegration compared to Z2 and T implants and, (v) 
radiographic marginal bone levels in all groups were stable during the entire experimental 
period. 
Several preclinical studies previously investigated loaded zirconia implants (Akagawa, 
Ichikawa, Nikai, Tsuru, 1993; Delgado-Ruiz, et al., 2014; Janner, et al., 2018; Kohal, Weng, 
Bachle, Strub, 2004; Thoma, et al., 2015; Thoma, et al., 2016). All those studies assessed hard 
tissue healing, i.e. osseointegration and marginal bone level change, but only a limited number 
of studies evaluated the soft tissue response (Kohal, et al., 2004; Thoma, et al., 2015). Moreover, 
no study has been performed to analyze tissue integration at zirconia implants with dehiscence 
defects under loading condition. 
In a pilot study (Lim, et al., 2018), the present chronic buccal dehiscence model was validated. 
In that study, the level of a buccal dehiscence defect appeared to be stable around implants up 
to 6 weeks of healing. Moreover, there was no substantial decrease in the dimension of peri-
implant mucosa in Z1_D and T_D even though a slight apical shift of the margo mucosae was 
observed. However, the findings were limited to an early healing phase (2 and 6 weeks only), 
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leaving some doubts on the potential stability of the peri-implant mucosa following prosthesis 
insertion and subsequent loading. 
In the present study, all groups demonstrated an apical shift of the margo mucosae. Such 
changes (irrespective of the implant materials) might be due to tissue maturation, prosthetic 
procedures and loading. Even though, only groups Z1_D (median= -0.52, Q1= -0.65; Q3= -
0.32) and T_D exhibited a borderline statistical significance, the median values of this apical 
shift were more pronounced around titanium (median= -1.4; Q1= -1.86; Q3= 0.21 mm for 
group T, median= -1.26; Q1= -1.47; Q3= -0.5 mm for group T_D) than for zirconia implants. 
Clinically, untreated implant dehiscence defects at titanium implants demonstrated to result in 
a stable margo mucosae on the short-term, but a higher risk to develop peri-implant disease on 
the long-run (Jung, et al., 2017; Schwarz, Sahm, Becker, 2012). The present preclinical study, 
provides first evidence that in case of untreated dehiscence defects, zirconia implants might be 
more favorable (less recession) than standard titanium implants if implant threads are left 
exposed. One can only speculate on the reasons for such differences: i) implant design, ii) 
implant surface, iii) soft tissue seal around the implant neck, iv) the number of leukocytes 
present around titanium and zirconia implants (Welander, et al., 2008), v) the number of 
bacteria present around titanium and zirconia implants (Rimondini, Cerroni, Carrassi, Torricelli, 
2002).  
Interestingly, observational studies demonstrated stable marginal gingival levels around 
titanium implants in case of missing buccal bone (Benic, et al., 2012; Kuchler, et al., 2016). 
Several reasons could be extrapolated for this observed partial or complete loss of buccal bone 
plate, but the finding could be interpreted as being that soft tissue compensated for missing 
hard tissue. In contrast to the present investigation with chronic ridge defects and late implant 
placement, only immediately placed implants (with simultaneous guided bone regeneration) 
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were included in those two studies, thereby adding an additional confounding factor.  
Even though an apical shift of the margo mucosa was observed in both groups with untreated 
dehiscence defects (Z1_D, T_D), a significant change in the height of the peri-implant mucosa 
was only noted in group T_D. Both hard and soft tissue changes can be responsible. In the pilot 
experiment for the present study, a minimal hard tissue change was noted, but the limitations 
were a small number of experimental animals, a short observation period and no loading of the 
implants (Lim, et al., 2018). In the present study, even though group T_D demonstrated a 
median bone gain over time (0.71 mm), the soft tissue loss (median loss = 1.26 mm) eventually 
resulted in a significant loss of the height of the peri-implant mucosa. Moreover, less changes 
in both hard (median gain = 0.09 mm) and soft tissue levels (median loss = 0.52 mm) were 
noted in group Z1_D. In the above-mentioned clinical study, a re-entry procedure was 
performed for all implants in order to connect the abutments (Jung, et al., 2017), revealing 
approximately 42 % of the implants with untreated dehiscence defect loosing buccal bone. This 
contradictory finding is attributable to the concept of implant placement; bone-driven implant 
placement for the present preclinical study and prosthetically driven placement for the above 
clinical study. Nonetheless, in both studies, titanium implants were negatively influenced by 
the presence of buccal dehiscence defect. 
Systematic review based on preclinical studies demonstrated that zirconia implants led to 
similar bone-to-implant contact (BIC) to titanium implant in most of the included studies 
(Manzano, Herrero, Montero, 2014). On the basis of the data from groups without dehiscence 
defects, zirconia implant groups (groups Z1, Z2) demonstrated comparable BIC values to 
titanium implants (group T). It was also noticeable that group Z1 yielded higher BIC values 
compared to group Z2 at both time points (median value: 46.49 vs. 36.66%; p<0.05 at 2 weeks, 
83.53 vs. 74.28%; p>0.05 at 6 months loading). A modified zirconia implant surface (Z1) led 
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to a faster and an enhanced osseointegration compared to the non-modified surface (Z2).  
The marginal bone level changes of zirconia implants and titanium implants in the present 
study demonstrated stability for both implant materials. The statistically significant changes 
for Z1 and T between implant placement and crown insertion appeared to be a physiological 
adaptation of the marginal bone (Abrahamsson, Berglundh, Moon, Lindhe, 1999; Ericsson, 
Nilner, Klinge, Glantz, 1996). There was no further significant loss of marginal bone after 
crown insertion in all groups, irrespective of the presence of a dehiscence defect.  
The limitation of the present preclinical study is different behavioral and physiologic responses 
of an animal model compared to a clinical situation. Any translation of the present data into 
daily practice should be done with care. Even though zirconia implant demonstrated a potential 
to maintain the height of the peri-implant mucosa in the presence of a buccal bone dehiscence 
defect, this cannot be generalized and directly transferred to human patients. Rather, on the 
basis of these preclinical results, clinical studies should be performed to evaluate a potential 
clinical benefit of zirconia implants on the level of the soft tissues.  
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Conclusion 
The margo mucosae shifted apically to a greater extent at titanium than at zirconia implants 
with dehiscence defects. Despite concomitant hard tissue changes in both Z1 and T implants 
with dehiscence defects, a significant loss of the height of peri-implant mucosa was only 
observed for T implants. Osseointegration was enhanced in Z1 implant with a modified surface 
compared to Z2 implant. Radiographic marginal bone levels were stable irrespective of implant 
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Figure 1. Detailed schedule of surgical and prosthetic procedures, and sacrifices 
Figure 2. Representative clinical photographs. (A) five implants with/without bony dehiscence 
defect were placed and healing abutments were connected. (B) clinical healing after 8 weeks 
of healing (mild gingival inflammation was observed around T implant). (C) prefabricated 
CAD/CAM crowns were inserted. (D) clinical healing after 6 months of loading. 
Figure 3. Histomorphometric assessments. (A) Linear measurement. (B) BIC. BIC: bone-to-
implant contact, MM: margo mucosa, IS: implant shoulder, aJE: apical extension of the 
junctional epithelium, BC: bone crest, fBIC: the first bone-to-implant contact. 
Figure 4. Representative histologic views at 2 weeks of healing and at 6 months of loading 




















Table 1. Linear measurement on the soft tissue level  
 Z1 Z2 T Z1_D T_D 
2 weeks of healing [median (Q1; Q3), mean ± standard deviation] 
MM-IS 
1.85 (1.57; 2.07), 
2.03±0.64 
1.64 (1.44; 2.02), 
1.97±0.93 
2.64 (1.68; 3.47), 
2.61±0.88 
1.63 (1.57; 3.09), 
2.09±0.78 
2.15 (1.92; 2.44), 
2.19 ±0.57 
MM-aJE 
0.88 (0.29; 1.01), 
0.86±0.76 
0.62 (0; 1.65), 
0.79±0.85 
1.63 (0.08; 2.04), 
1.49±1.34 
1.0 (0.56; 2.57), 
1.45±1.28 
1.90 (1.14; 2.65), 
2.02±1.38 
MM-fBIC 
3.29 (2.88; 4.04), 
3.52±0.85 
3.29 (2.90; 3.78), 
3.42±0.63 
3.74 (3.08; 4.02), 
3.80±2.85 
5.14 (4.55; 5.23), 
5.14±1.33 
5.43 (5.19; 5.88), 
5.44±0.75 
IS-fBIC_c* 
0.80 (0.43; 1.02), 
0.78±0.48 
0.64 (0.31; 1.31), 
0.74±0.60 
0.87 (0.77; 1.11), 
0.78±0.51 
2.81 (2.31; 2.96), 
2.34±1.43 
2.91 (2.53; 3.16), 
2.85±0.31 
BC-fBIC 
0.21 (0.09; 0.97), 
0.44±0.46 
0.07 (0; 0.46), 
0.34±0.55 
0.2 (0.04; 0.51), 
0.25±0.23 
0.04 (0; 0.4), 
0.15±0.21 
0.21 (0.13; 0.44), 
0.42±0.56 
6 months of loading [median (Q1; Q3), mean ± standard deviation] 
MM-IS 
1.30 (1.10; 1.49), 
1.46±0.87 
1.49 (1.11; 1.99), 
1.77±1.02 
1.63 (1.13; 2.11), 
1.76±0.85 
1.23 (1.01; 1.58), 
1.51±0.84¶ 
1.27 (0.21; 1.60), 
1.12±0.80¶ 
MM-aJE 
2.45 (1.0; 3.11), 
2.09±1.26 
0.85 (0.52; 1.37), 
1.11±0.82 
2.02 (0.89; 2.11), 
1.86±0.88 
1.0 (0.44; 1.98), 
1.28±1.16 
1.27 (0.29; 1.60), 
1.37±1.21 
MM-fBIC* 
3.76 (3.61; 4.24), 
3.88±0.46 
3.86 (3.14; 4.80), 
3.83±1.0 
3.59 (3.27; 3.73), 
3.33±0.67 
4.51 (4.30; 4.60), 
4.44±0.44 
3.95 (3.24; 4.31), 
3.83±0.58¶ 
IS-fBIC_c* 
1.76 (1.54; 2.40), 
1.72±0.73 
0.82 (0.46; 2.33), 
1.36±1.19 
1.14 (0.49; 1.58), 
1.17±0.87 
2.65 (1.90; 2.83), 
2.23±0.95 
2.01 (1.23; 3.60), 
2.30±1.26 
BC-fBIC 
0.09 (0; 0.42), 
0.18±0.23 
0.58 (0.40; 0.71), 
0.72±0.61 
0 (0; 0), 
0.01±0.02¶ 
0.23 (0.12; 0.45), 
0.34±0.36 
0 (0; 0), 
0±0 
Change between two time points 
MM-IS 
-0.36 (-0.58; -0.17), 
-0.5±1.38 
-0.62 (-0.67; 0.67), 
-0.21±1.47 
-1.40 (-1.86; 0.21), 
-0.86±1.44 
-0.52 (-0.65; -0.32), 
-0.58±0.52 
-1.26 (-1.47; -0.50), 
-1.06±0.81 
MM-aJE 
1.90 (1.12; 3.01), 
1.60±1.68 
0.54 (-0.92; 1.37), 
0.32±1.16 
0.68 (-0.45; 1.97), 
0.37±1.79 
-0.04 (-1.08; 1.23), 
-0.17±1.76 
-0.62 (-2.19; 1.27), 
0.37±1.79 
MM-fBIC 
0.58 (0.19; 0.96), 
0.47±1.04 
0.42 (-0.34; 1.13), 
0.41±1.15 
-0.35 (-1.77; 0.64), 
-0.47±1.18 
-0.54 (-1.53; -0.13), 
-0.69±1.59 
-1.45 (-2.42; -1.06), 
-0.47±1.18† 
IS-fBIC_c 
1.04 (0.84; 1.51), 
0.95±1.11 
0.68 (-0.85; 1.80), 
0.62±1.46 
0.37 (-0.31; 0.94), 
0.39±0.80 
-0.09 (-1.06; 0.52), 
-0.11±2.08 
-0.71 (-1.77; 0.68), 
-0.55±1.40 
BC-fBIC 
-0.14 (-0.93; 0.29), 
-0.26±0.57 
0.31 (0.17; 0.66), 
0.39±0.88 
-0.20 (-0.49; -0.04), 
-0.24±0.22 
0.09 (-0.08; 0.33), 
0.19±0.45 
-0.21 (-0.44; -0.13), 
-0.42±0.56 
Z1: zirconia implant with modified surface, placed within the bony housing, Z2: zirconia implant without 
modified surface, placed within the bony housing, T: titanium implant placed within the bony housing, 
Z1_D: Z1 implant placed with 3 mm of buccal bone dehiscence, T_D: titanium implant placed with 3 mm 
of buccal bone dehiscence, MM: the margo mucosa, IS: the implant shoulder, aJE: the apical extension of 
the junctional epithelium, fBIC: the first bone-to-implant contact, BC: the bone crest, IS-fBIC_c: the 
distance between IS and fBIC, subtracted by 0.7mm (zirconia implant) or 0.4mm (titanium implant). 
*statistically significant group effect within each time point 
¶statistically significant time effect in each group 
†statistically significant change compared to “0” change 
Table 2. Bone-to-implant contact ratio (%) 
Z1 Z2 T Z1_D T_D 































Z1: zirconia implant with modified surface, placed within the bony housing, Z2: zirconia implant without 
modified surface, placed within the bony housing, T: titanium implant placed within the bony housing, 
Z1_D: Z1 implant placed with 3 mm of buccal bone dehiscence, T_D: titanium implant placed with 3 mm 
of buccal bone dehiscence, MM: the margo mucosa, IS: the implant shoulder, aJE: the apical extension of 
the junctional epithelium, fBIC: the first bone-to-implant contact, BC: the bone crest, IS-fBIC_c: the 
distance between IS and fBIC, subtracted by 0.7mm (zirconia implant) or 0.4mm (titanium implant).  
*statistically significant group effect within each time point 
¶statistically significant time effect in each group 
 
Table 3. Changes of radiographical marginal bone level 
 Z1 Z2 T Z1_D T_D 






































































Z1: zirconia implant with modified surface, placed within the bony housing, Z2: zirconia implant without 
modified surface, placed within the bony housing, T: titanium implant placed within the bony housing, 
Z1_D: Z1 implant placed with 3 mm of buccal bone dehiscence, T_D: titanium implant placed with 3 mm 
of buccal bone dehiscence, MM: the margo mucosa, IS: the implant shoulder, aJE: the apical extension of 
the junctional epithelium, fBIC: the first bone-to-implant contact, BC: the bone crest, IS-fBIC_c: the 
distance between IS and fBIC, subtracted by 0.7mm (zirconia implant) or 0.4mm (titanium implant).  
†statistically significant change compared to “0” change 
 
